Medical Oncology

Uzm. Dr. İlker Nihat Ökten

Doctor and researcher Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi İstanbul
Breast NeoplasmsLung NeoplasmsEchinococcosis, PulmonaryAdenocarcinomaStomach NeoplasmsLiver NeoplasmsCarcinoma, Squamous CellColorectal NeoplasmsRespiratory Insufficiency
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 9 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Lung Neoplasms 3 publications
  • Echinococcosis, Pulmonary 3 publications
  • Adenocarcinoma 2 publications
  • Stomach Neoplasms 2 publications
  • Liver Neoplasms 2 publications
  • Carcinoma, Squamous Cell 2 publications
  • Colorectal Neoplasms 2 publications
  • Respiratory Insufficiency 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologysaglik.gov.trFrom source
  • InstitutionGöztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesisaglik.gov.trFrom source
  • Area of workBreast NeoplasmsExtracted from 9 publications · Model version —From source
  • Publications114 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0003-2360-3392ORCIDFrom source
  • Last synchronised5 November 2026 08:56https://suleymanyalcinsh.saglik.gov.tr/TR-1493558/doktorlarimiz.html#ilker-nihat-oktensaglik.gov.tr

Scientific work

Publications on Breast Neoplasms

114 publications

  1. First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis

    Medicina, 2026

    DOI 10.3390/medicina62050984 PMID 42195237 Open-access full textSource: OpenAlex

  2. Revisiting Platinum Sensitivity in Relapsed Small-Cell Lung Cancer: Outcomes of Platinum-Containing Doublet Chemotherapy in the 3–6 Month Relapse Window

    Current Oncology, 2026

    DOI 10.3390/curroncol33080472 PMID 42645377 Open-access full textSource: OpenAlex

  3. Clinical Characteristics, Treatment Patterns, and Survival Outcomes of Right-Sided RAS/RAF Wild-Type Metastatic Colorectal Cancer: A Real-World Multicenter Cohort Study

    Clinics and Practice, 2026

    DOI 10.3390/clinpract16090158 PMID 42783081 Open-access full textSource: OpenAlex

  4. Real-World Survival Outcomes Following Metastasectomy in RAS Wild-Type mCRC: Insights from a Multicentre National Cohort Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15020467 PMID 41598406 Open-access full textSource: ORCID

  5. Comparable Access, Different Outcomes: Breast Cancer Survival Among Syrian Refugees and Turkish Patients in Türkiye

    Current Oncology, 2026

    DOI 10.3390/curroncol33030155 PMID 41892183 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  6. Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

    Current Oncology, 2026

    DOI 10.3390/curroncol33060365 PMID 42346265 Open-access full textSource: OpenAlex

  7. Baseline [¹⁸F]FDG PET/CT metrics and systemic inflammatory indices in relation to overall survival in a real-world breast cancer cohort

    Clinical and Translational Imaging, 2026

    DOI 10.1007/s40336-026-00767-7 Source: OpenAlex

  8. The Effect of MCV on Prognosis in Patients with Gastric Cancer and its Relationship with C-ERBB2 Positivity

    Eurasian Journal of Medical Advances, 2026

    DOI 10.14744/ejma.260309 Open-access full textSource: OpenAlex

  9. Risk Tier, Variant Certainty, and Real-World Care Patterns in Breast Cancer Patients with Germline Alterations in Breast Cancer Susceptibility Genes

    Cancers, 2026

    DOI 10.3390/cancers18101499 PMID 42192861 Open-access full textSource: ORCID

  10. Prognostic Impact of Ectopic Fat Deposition Within the Psoas Muscle in Patients with Stage IV Pancreatic Cancer Receiving Systemic Chemotherapy

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15103936 PMID 42194896 Open-access full textSource: OpenAlex

View all 114 publications